LOTTE Biologics to Participate in DCAT Week 2026 in New York

Seoul [South Korea], March 9: LOTTE Biologics announced today that it will participate in DCAT Week 2026, a global...

Morepen Bags Rs. 825 Crore Global Deal

Gurugram (Haryana) [India], February 23: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a...

Sai Life Sciences to Recruit 700+ Professionals in FY27

Hyderabad (Telangana) [India], February 20: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's...

Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue

New Delhi [India], February 14: Akums Drugs & Pharmaceuticals Ltd., India's Largest Contract Development and...

Akums Reports Q2 FY26 Results; Strengthens International Presence

New Delhi [India], November 14: Akums Drugs & Pharmaceuticals Ltd., India's Largest Contract Development and...

Sai Life Sciences to Recruit 200 Scientists in November

Hyderabad (Telangana) [India], November 11: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's...

Sai Life Sciences Set to Double Process R&D Capacity

Hyderabad (Telangana) [India], October 28: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's...

Sai Life Sciences Opens Facility for Veterinary APIs in Bidar

Hyderabad (Telangana) [India], September 19: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused...

Akums Reports Q1 FY26 with 19% YoY Adj EBITDA Growth

New Delhi [India], August 9: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and...

Indian CRDMOs benefiting from diversification by global pharma

Indian CRDMOs (Contract Research and Development and Manufacturing Organizations) are seeing growing interest from...

Zydus to Enter Global Biologics CDMO Business Plans

New Jersey [US]/ Ahmedabad (Gujarat) [India], June 3: Zydus Lifesciences Ltd. (including its...

Akums Reports Q4 FY25 with 12.4% Revenue Growth

New Delhi [India], May 27: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and...